Real-World Experience of Cryopreserved Allogeneic Hematopoietic Grafts during the COVID-19 Pandemic: A Single-Center Report

In response to the widespread COVID-19 pandemic, cryopreservation of allogeneic donor apheresis products was implemented to mitigate the challenges of donor availability and product transport. Although logistically beneficial, the impact of cryopreservation on clinical outcomes and graft composition...

Descripción completa

Detalles Bibliográficos
Autores principales: Bankova, Andriyana K., Caveney, Joseph, Yao, Bin, Ramos, Teresa L., Bögeholz, Jan, Heydari, Kartoosh, Diaz, Nery, Jackson, Marin L., Lowsky, Robert, Brown, Janice (Wes), Johnston, Laura, Rezvani, Andrew R., Frank, Matthew J., Muffly, Lori, Weng, Wen-Kai, Sidana, Surbhi, Negrin, Robert S., Miklos, David B., Shiraz, Parveen, Meyer, Everett H., Shizuru, Judith A., Arai, Sally
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy. 2022
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760704/
https://www.ncbi.nlm.nih.gov/pubmed/35042013
http://dx.doi.org/10.1016/j.jtct.2022.01.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760704/
https://www.ncbi.nlm.nih.gov/pubmed/35042013
http://dx.doi.org/10.1016/j.jtct.2022.01.010

Ejemplares similares